| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Bienaime Jean Jacques is a Director at BIOMARIN PHARMACEUTICAL INC with holdings across 6 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $30.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,000 | $88.49 | $707,920.00 | -2.3% | |
| Dec 30, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,000 | $83.60 | $668,760.00 | -2.3% | |
| Nov 22, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 139,487 | $86.62 | $12,082,992.56 | -29.0% | |
| Nov 16, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 41,670 | $90.97 | $3,790,794.91 | -11.4% | |
| Nov 8, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 140,000 | $82.67 | $11,574,241.00 | -17.8% | |
| Oct 28, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 120,000 | $81.30 | $9,756,438.00 | -15.7% | |
| Oct 17, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 41,666 | $84.39 | $3,516,227.07 | -11.4% | |
| Oct 14, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 64,125 | $86.96 | $5,576,377.01 | -9.0% | |
| Sep 30, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 53,125 | $92.02 | $4,888,780.31 | -12.3% | |
| Sep 29, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 53,125 | $93.65 | $4,974,901.25 | -12.3% |